Literature DB >> 8422018

Changing etiology of macrocytosis. Zidovudine as a frequent causative factor.

D P Snower1, S C Weil.   

Abstract

Macrocytosis is most commonly associated with vitamin B12 and folate deficiencies, followed by alcoholism, liver disease, and malignant neoplasms. Many laboratories have observed that in recent years macrocytosis increasingly has been associated with zidovudine treatment of acquired immune deficiency syndrome. One hundred consecutive inpatients in a large metropolitan urban hospital with mean corpuscular volumes greater than 110 fL were studied; 44% were patients with acquired immune deficiency syndrome being treated with zidovudine, 19% were alcoholics, and 12% had malignant neoplasms. Only 3% were folate deficient and just 4% were vitamin B12 deficient. This study suggests that zidovudine has become the most common cause of macrocytosis in the hospitalized urban patient population and that vitamin B12 and folate deficiencies have decreased in proportion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422018     DOI: 10.1093/ajcp/99.1.57

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

Review 1.  Macrocytosis: pitfalls in testing and summary of guidance.

Authors:  Michael Galloway; Malcolm Hamilton
Journal:  BMJ       Date:  2007-10-27

2.  A review of the use of blood and blood products in HIV-infected patients.

Authors:  Karin van den Berg; James van Hasselt; Evan Bloch; Robert Crookes; James Kelley; Jonathan Berger; Charlotte Ingram; Anel Dippenaar; Rajendra Thejpal; Neil Littleton; Tersia Elliz; Gary Reubenson; Mark Cotton; Jennifer C Hull; Pamela Moodley; Yasmin Goga; William Eldridge; Moosa Patel; Eric Hefer; Arthur Bird
Journal:  South Afr J HIV Med       Date:  2012-06-07       Impact factor: 2.744

3.  [Macrocytosis without anaemia in an urban population].

Authors:  Paloma Domínguez Ruiz de León; Victoria Morcillo Cebolla; Blanca Gutiérrez Parres; Francisco Javier Cirujano Pita; Elvira Díaz de Tuesta Díaz de Lezama; Elena Mazorra Benito
Journal:  Aten Primaria       Date:  2010-07-08       Impact factor: 1.137

Review 4.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.